Nearly half of cancers worldwide can be traced back to a known risk factor, primarily tobacco or alcohol, a huge global study found on Friday, which said that behavioral changes can help reduce the threat of disease.
Aug 19, 2022
0
371
New research being presented at this year's European Congress on Obesity (ECO) in Maastricht, Netherlands (4-7 May), suggests secondary school pupils across the West Midlands region of the UK are not eating a healthy, sustainable ...
May 4, 2022
0
57
The NRG Oncology clinical trial NRG-RTOG 1010, studying the addition of the drug trastuzumab to chemoradiation and surgery, did not reach its primary goal of improving disease-free survival (DFS) rates for patients with HER2 ...
Jan 21, 2022
0
15
Diagnostics have proven to be crucial to the COVID-19 pandemic response.
Dec 21, 2021
0
19
Researchers at Karolinska Institutet in Sweden recently reported that magnetic resonance imaging (MRI) could reduce overdiagnoses and thereby improve prostate cancer screening. Now, the same research group has published a ...
Aug 13, 2021
0
288
Argenx, a Belgium pharmaceutical company, recently announced that The Lancet Neurology has published pivotal trial results from the Phase 3 ADAPT trial of efgartigimod, an FcRn antagonist, for the treatment of adults living ...
Jun 18, 2021
0
3
The first thing to know is: The COVID vaccines are safe, effective, and necessary. Doctors recommend them and the vaccines are available to everyone ages 12 and older in New York state.
Jun 8, 2021
0
7
A superficial reading of the history of vaccination might lead you to believe that it is simple. Dried smallpox pustules had been used for 1,000 years to inoculate people against smallpox before the first successful vaccine ...
May 20, 2021
0
5
Scientists from the University of Oxford, working as part of the EBOVAC2 EBL2001 study group, have today announced the results of a phase 2 trial of a replication-deficient adenovirus vaccine aimed at providing protection ...
Nov 18, 2020
0
8
The prestigious Lancet medical journal said it is bolstering its scientific review process after being forced to retract a study into the effects of an anti-arthritis drug on COVID-19 patients.
Sep 18, 2020
0
51
